Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Red cell exchange for rapid leukoreduction in adults with hyperleukocytosis and leukostasis

Ethan A. Mack, Meaghan C. Dougher, Ashley M. Ginda, Caitlin Cahill, Melissa Murter, Kevin Schell, Yvette C. Tanhehco, Vijay G. Bhoj, Andrew D. Fesnak, Don L. Siegel, Taku Kambayashi, Nicole A. Aqui, Una O’Doherty

Blood (2024) 143 (11): 1049–1054.

https://doi.org/10.1182/blood.2023021895

Published: 2024

Journal Articles

The Thrombotic Microangiopathy Registry of North America

Ara Metjian, MD, Yvette Tanhehco, MD, Huy Phu Pham, MD, M.P.H., Nicole A. Aqui, MD, Vijay Bhoj, MD PhD, Oluwatoyosi Onwuemene, MD, Marisa Marques, MD, Gowthami M Arepally, MD

Blood (2015) 126 (23): 5587.

https://doi.org/10.1182/blood.V126.23.5587.5587

Published: 2015

Journal Articles

Adoptive Immunotherapy With Autologous CD3/CD28-Costimulated T-Cells After Fludarabine-Based Chemotherapy In Patients With Chronic Lymphocytic Leukemia

Stephen J. Schuster, MD, Chitra M. Hosing, MD, Elizabeth J Shpall, MD, Bruce L. Levine, PhD, Nicole A. Aqui, MD, Elise A. Chong, MD, Jakub Svoboda, MD, Doyle Bosque, ADN, Julio Cotte, Zhaohui Zheng, Indreshpal Kaur, PhD, Elizabeth Veloso, JD, BSN, Catherine M. Bollard, MBChB, MD, Michael J. Keating, MD, Carl H. June, MD

Blood (2013) 122 (21): 2874.

https://doi.org/10.1182/blood.V122.21.2874.2874

Published: 2013

Journal Articles

High Response Rate To Combination Lenalidomide-Rituximab In FcγRIIIa-F Carriers With Indolent Or Mantle Cell Lymphomas Previously Refractory To Rituximab

Elise A. Chong, MD, Tahamtan Ahmadi, MD, PhD, Nicole A. Aqui, MD, Sunita D. Nasta, MD, Jakub Svoboda, MD, Kristy M. Walsh, BS, Amanda Gordon, CRNP, Stephen J. Schuster, MD

Blood (2013) 122 (21): 250.

https://doi.org/10.1182/blood.V122.21.250.250

Published: 2013

Journal Articles

Combination Immunotherapy After ASCT for Multiple Myeloma (MM) Using MAGE-A3/Poly-ICLC Immunizations Followed by Vaccine-Primed and Activated Autologous T-Cells

Blood (2012) 120 (21): 352.

https://doi.org/10.1182/blood.V120.21.352.352

Published: 2012

Journal Articles

Adoptive Transfer of Autologous CD25-Depleted, CD3/CD28-Costimulated T Cells After Cyclophosphamide - Fludarabine Chemotherapy in Patients with Low-Grade Follicular Lymphoma: Long-Term Follow up

Stephen J. Schuster, MD, Nicole A. Aqui, MD, Benjamin Musher, MD, Bruce L. Levine, PhD, Charalambos Andreadis, MD, MS, Elise A. Chong, BA, Sunita D. Nasta, MD, Amanda Gordon, CRNP, Julio Cotte, Zhaohui Zheng, MA, Andrea L. Brennan, Elizabeth Veloso, JD, BSN, Carl H. June, MD

Blood (2012) 120 (21): 1631.

https://doi.org/10.1182/blood.V120.21.1631.1631

Published: 2012

Journal Articles

Phase II Trial of Lenalidomide - Rituximab +/− Dexamethasone in Relapsed or Refractory Indolent B-Cell or Mantle Cell Lymphomas Resistant to Rituximab

Tahamtan Ahmadi, MD, PhD, Elise A. Chong, BA, Amanda Gordon, CRNP, Nicole A. Aqui, MD, YinYan Xu, Jakub Svoboda, MD, Sunita D. Nasta, MD, Stephen J. Schuster, MD

Blood (2011) 118 (21): 266.

https://doi.org/10.1182/blood.V118.21.266.266

Published: 2011

Journal Articles

Adoptive Immunotherapy with Autologous CD3/CD28-Costimulated T-Cells After Fludarabine-Based Chemotherapy in Patients with Chronic Lymphocytic Leukemia

Blood (2011) 118 (21): 2855.

https://doi.org/10.1182/blood.V118.21.2855.2855

Published: 2011

Journal Articles

Combination immunotherapy using adoptive T-cell transfer and tumor antigen vaccination on the basis of hTERT and survivin after ASCT for myeloma

Blood (2011) 117 (3): 788–797.

https://doi.org/10.1182/blood-2010-08-299396

Published: 2011

Includes: Supplemental data

Journal Articles

Transfer of influenza vaccine–primed costimulated autologous T cells after stem cell transplantation for multiple myeloma leads to reconstitution of influenza immunity: results of a randomized clinical trial

Edward A. Stadtmauer, Dan T. Vogl, Eline Luning Prak, Jean Boyer, Nicole A. Aqui, Aaron P. Rapoport, Kenyetta R. McDonald, Xiaoling Hou, Heather Murphy, Rita Bhagat, Patricia A. Mangan, Anne Chew, Elizabeth A. Veloso, Bruce L. Levine, Robert H. Vonderheide, Abbas F. Jawad, Carl H. June, Kathleen E. Sullivan

Blood (2011) 117 (1): 63–71.

https://doi.org/10.1182/blood-2010-07-296822

Published: 2011

Journal Articles

Phase II Trial of Lenalidomide - Dexamethasone - Rituximab In Relapsed or Refractory Indolent B-Cell or Mantle Cell Lymphomas Resistant to Rituximab

Tahamtan Ahmadi, Elise A. Chong, Amanda Gordon, Leah Leinbach, Nicole A. Aqui, Sunita D. Nasta, Jakub Svoboda, Steven C. Goldstein, Stephen J. Schuster

Blood (2010) 116 (21): 3962.

https://doi.org/10.1182/blood.V116.21.3962.3962

Published: 2010

Journal Articles

Phase II Trial of Lenalidomide - Dexamethasone - Rituximab in Relapsed or Refractory Indolent B-Cell or Mantle Cell Lymphomas Resistant to Rituximab.

Tahamtan Ahmadi, MD, PhD, Elise A. Chong, BA, Amanda Gordon, BA, BSN, RN, Nicole A. Aqui, MD, Lisa H. Downs, CRNP, Leah Leinbach, Steven C. Goldstein, MD, Sunita D. Nasta, MD, Stephen Janofsky, Tapan N. Maniar, MD, Jakub Svoboda, MD, Stephen J. Schuster, MD

Blood (2009) 114 (22): 1700.

https://doi.org/10.1182/blood.V114.22.1700.1700

Published: 2009

Journal Articles

Schedule Dependent Effects of Adoptively Transferred Autologous T Cells After AutoSCT for Myeloma: Accelerated Immune Recovery Is Associated with Improved Event-Free Survival.

Blood (2009) 114 (22): 784.

https://doi.org/10.1182/blood.V114.22.784.784

Published: 2009

Journal Articles

Influenza (flu) Vaccine Administration to Patients with Multiple Myeloma (MM) Prior to Autologous T-Cell Harvest Leads to Better Reconstitution of Flu Immunity After High Dose Melphalan and Autologous Stem Cell Transplant (ASCT) and Reinfusion of Primed Ex-Vivo Co-Stimulated Autologous T-Cells and Post-ASCT Second Flu Vaccination Than Post-ASCT Flu Vaccination Alone.

Edward A. Stadtmauer, MD, Dan T. Vogl, MD, Nicole A. Aqui, MD, Aaron P. Rapoport, MD, Kenyetta Macdonald, Heather Murphy, Rita Bhagat, RN, Patricia A. Mangan, APRN, BC, Anne Chew, PhD, Elizabeth Veloso, RN, JD, Bruce Levine, PhD, Robert H. Vonderheide, MD, DPhil, Carl H. June, MD, Kathleen Sullivan, MD

Blood (2009) 114 (22): 797.

https://doi.org/10.1182/blood.V114.22.797.797

Published: 2009

NARROW

Red cell exchange for rapid leukoreduction in adults with hyperleukocytosis and leukostasis

The Thrombotic Microangiopathy Registry of North America

Adoptive Immunotherapy With Autologous CD3/CD28-Costimulated T-Cells After Fludarabine-Based Chemotherapy In Patients With Chronic Lymphocytic Leukemia

High Response Rate To Combination Lenalidomide-Rituximab In FcγRIIIa-F Carriers With Indolent Or Mantle Cell Lymphomas Previously Refractory To Rituximab

Combination Immunotherapy After ASCT for Multiple Myeloma (MM) Using MAGE-A3/Poly-ICLC Immunizations Followed by Vaccine-Primed and Activated Autologous T-Cells

Adoptive Transfer of Autologous CD25-Depleted, CD3/CD28-Costimulated T Cells After Cyclophosphamide - Fludarabine Chemotherapy in Patients with Low-Grade Follicular Lymphoma: Long-Term Follow up

Phase II Trial of Lenalidomide - Rituximab +/− Dexamethasone in Relapsed or Refractory Indolent B-Cell or Mantle Cell Lymphomas Resistant to Rituximab

Adoptive Immunotherapy with Autologous CD3/CD28-Costimulated T-Cells After Fludarabine-Based Chemotherapy in Patients with Chronic Lymphocytic Leukemia

Combination immunotherapy using adoptive T-cell transfer and tumor antigen vaccination on the basis of hTERT and survivin after ASCT for myeloma

Transfer of influenza vaccine–primed costimulated autologous T cells after stem cell transplantation for multiple myeloma leads to reconstitution of influenza immunity: results of a randomized clinical trial

Phase II Trial of Lenalidomide - Dexamethasone - Rituximab In Relapsed or Refractory Indolent B-Cell or Mantle Cell Lymphomas Resistant to Rituximab

Phase II Trial of Lenalidomide - Dexamethasone - Rituximab in Relapsed or Refractory Indolent B-Cell or Mantle Cell Lymphomas Resistant to Rituximab.

Schedule Dependent Effects of Adoptively Transferred Autologous T Cells After AutoSCT for Myeloma: Accelerated Immune Recovery Is Associated with Improved Event-Free Survival.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only